Histone deacetylases (HDACs): characterization of the classical HDAC family

被引:2467
作者
De Ruijter, AJM [1 ]
Van Gennip, AH [1 ]
Caron, HN [1 ]
Kemp, S [1 ]
Van Kuilenburg, ABP [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Paediat,Emma Childrens Hosp & Clin Chem, NL-1100 DE Amsterdam, Netherlands
关键词
characterization; inhibitor; co-repressor; gene expression; histone deacetylase; tissue distribution;
D O I
10.1042/BJ20021321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the posttranslational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation. Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect. Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones. The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity. SAGE (serial analysis of gene expression) data show that HDACs are generally expressed in almost all tissues investigated. Surprisingly, no major differences were observed between the expression pattern in normal and malignant tissues. However, significant variation in HDAC expression was observed within tissue types. HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis. This challenging field has generated many fascinating results Which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.
引用
收藏
页码:737 / 749
页数:13
相关论文
共 127 条
[81]   Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA [J].
Nair, AR ;
Boersma, LJ ;
Schiltz, L ;
Chaudry, A ;
Muschel, RJ .
CANCER LETTERS, 2001, 166 (01) :55-64
[82]  
Nervi C, 2001, CANCER RES, V61, P1247
[83]   The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein [J].
Nicolas, E ;
Ait-Si-Ali, S ;
Trouche, D .
NUCLEIC ACIDS RESEARCH, 2001, 29 (15) :3131-3136
[84]   Histone deacetylase 3 associates with and represses the transcription factor GATA-2 [J].
Ozawa, Y ;
Towatari, M ;
Tsuzuki, S ;
Hayakawa, F ;
Maeda, T ;
Miyata, Y ;
Tanimoto, M ;
Saito, H .
BLOOD, 2001, 98 (07) :2116-2123
[85]  
Pelidis MA, 1998, INT J ONCOL, V12, P889
[86]   Histone deacetylase I phosphorylation promotes enzymatic activity and complex formation [J].
Pflum, MKH ;
Tong, JK ;
Lane, WS ;
Schreiber, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :47733-47741
[87]   Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report [J].
Piekarz, RL ;
Robey, R ;
Sandor, V ;
Bakke, S ;
Wilson, WH ;
Dahmoush, L ;
Kingma, DM ;
Turner, ML ;
Altemus, R ;
Bates, SE .
BLOOD, 2001, 98 (09) :2865-2868
[88]  
Pili R, 2001, CANCER RES, V61, P1477
[89]   Chronic oral administration of CI-994: A phase 1 study [J].
Prakash, S ;
Foster, BJ ;
Meyer, M ;
Wozniak, A ;
Heilbrun, LK ;
Flaherty, L ;
Zalupski, M ;
Radulovic, L ;
Valdivieso, M ;
LoRusso, PM .
INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) :1-11
[90]   Inhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates [J].
Remiszewski, SW ;
Sambucetti, LC ;
Atadja, P ;
Bair, KW ;
Cornell, WD ;
Green, MA ;
Howell, KL ;
Jung, M ;
Kwon, P ;
Trogani, N ;
Walker, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :753-757